Female Advantage in AMI Mortality Reversed in Type 2 Diabetes Patients

What is it about?

The study found that while there were no significant differences in risk factor levels between men and women at baseline, patients generally had more dyslipidemia and higher blood pressure and glucose than the reference population. After a mean follow-up of 8.1 years, there were 52 events of fatal AMI in men and 29 in women. Mortality rates were considerably lower in women than in men without type 2 diabetes, but they were higher in women than in men with type 2 diabetes. The age-adjusted hazard ratios for patients with type 2 diabetes compared with the population were 5.0 (2.4 -10.8) in women and 1.9 (1.1-3.2) in men. The study concluded that the interaction between sex and type 2 diabetes shows that the effect of type 2 diabetes on fatal AMI was significantly stronger in women than in men independent of other major cardiovascular risk factors. [Some of the content on this page has been created by AI]

Featured Image

Why is it important?

The study highlights the potential interaction between sex and type 2 diabetes in the risk of acute myocardial infarction (AMI). While the overall incidence of AMI is lower in women, the female advantage disappears in subjects with type 2 diabetes, and the risk is sometimes even higher in women than in men. This research is crucial as it demonstrates that the effect of type 2 diabetes on fatal AMI is significantly stronger in women than in men, independent of other major cardiovascular risk factors. Understanding this interaction can help improve prognosis for female patients with type 2 diabetes and highlights the need for more research on sex-specific mechanisms. Key Takeaways: 1. The study investigates the potential interaction between sex and type 2 diabetes in the risk of acute myocardial infarction (AMI). 2. Women with type 2 diabetes have a higher risk of fatal AMI than men with type 2 diabetes, independent of other risk factors. 3. The interaction between sex and type 2 diabetes suggests that the effect of type 2 diabetes on fatal AMI is stronger in women. 4. The study emphasizes the importance of understanding sex-specific mechanisms to improve prognosis for female patients with type 2 diabetes.